固体脂质纳米粒子和纳米结构脂质载体用于抗癌植物化学交付:进展,挑战和未来前景
Shery Jacob1, Rekha Rao2, Bapi Gorain3
1Department of Pharmaceutical Sciences, College of Pharmacy, Gulf Medical University, Ajman P.O. Box 4184, United Arab Emirates.
Pharmaceutics
|August 28, 2025
概括
基于脂质的纳米载体,如固体脂质纳米颗粒 (SLN) 和纳米结构的脂质载体 (NLC),可以增强抗癌植物化学物质的传递. 这些系统提高了溶解度,生物可用性和治疗效果,同时降低了毒性.
科学领域:
- 纳米医学
- 药理学
- 生物技术
背景情况:
- 植物化学物质具有显著的抗癌性质,但由于溶解性,生物可用性和稳定性差,在临床使用中面临挑战.
- 基于脂质的纳米载体,包括固体脂质纳米颗粒 (SLN) 和纳米结构脂质载体 (NLC),为克服这些局限性提供了有希望的解决方案.
研究的目的:
- 提供用于输送抗癌植物化学品的SLN和NLC的比较概述.
- 讨论这些纳米载体在增强抗癌活性中的配方方法,特征和作用.
- 探索用于癌症治疗的纳米载体开发的联合交付策略和未来方向.
主要方法:
- 对植物化学输送的SLN和NLC进行文献审查.
- 植物化学品根据化学结构和植物来源进行分类.
- 对脂质纳米载体的体外表征和配方技术的分析.
主要成果:
- 在SLN/NLC中封装黄素和白醇等植物化学物质可以提高治疗效果,减少细胞吸收,降低全身毒性.
- 在复杂的癌症中,同时使用的系统显示出协同作用的抗癌效应,使剂量减少和副作用最小化.
- 混合脂质聚合物纳米颗粒代表具有综合优势的先进载体.
结论:
- SLN和NLC是改善抗癌植物化学物质的有效平台.
- 进一步研究可扩展,仿生和响应刺激的纳米结构对于临床转化至关重要.
- 跨学科合作和监管协调对于开发可行的纳米医学平台至关重要.
相关概念视频
Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


